{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:12Z","timestamp":1791247932081,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61003-w","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:53:25Z","timestamp":1783317205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Iron excess is associated with atheroma presence and progression in chronic kidney disease in the NEFRONA cohort"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-0184","authenticated-orcid":false,"given":"Jose M.","family":"Valdivielso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Diaz-Tocados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Marti-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fernandez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraf\u00ed","family":"Cambray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelino","family":"Berm\u00fadez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"10","key":"61003_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","volume":"39","author":"JM Valdivielso","year":"2019","unstructured":"Valdivielso, J. M. et al. Atherosclerosis in chronic kidney disease: More, less, or just different?. Arterioscler. Thromb. Vasc. Biol. 39(10), 1938\u20131966 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"61003_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2215\/CJN.07980717","volume":"13","author":"M Bozic","year":"2018","unstructured":"Bozic, M. et al. Association of FGF-2 concentrations with atheroma progression in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 13(4), 577\u2013584 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"61003_CR3","doi-asserted-by":"publisher","first-page":"sfad257","DOI":"10.1093\/ckj\/sfad257","volume":"17","author":"S Cambray","year":"2024","unstructured":"Cambray, S. et al. Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort. Clin. Kidney J. 17(1), sfad257 (2024).","journal-title":"Clin. Kidney J."},{"key":"61003_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy207","author":"JM Valdivielso","year":"2018","unstructured":"Valdivielso, J. M. et al. Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfy207 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"61003_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","volume":"104","author":"E Ku","year":"2023","unstructured":"Ku, E. et al. Novel anemia therapies in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 104(4), 655\u2013680 (2023).","journal-title":"Kidney Int."},{"key":"61003_CR6","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfae075","volume":"39","author":"S Stoumpos","year":"2024","unstructured":"Stoumpos, S. et al. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European renal best practice board of the European renal association. Nephrol. Dial. Transplant. 39, 1710\u20131730 (2024).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10","key":"61003_CR7","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt, J. L. & Lin, H. Y. Mechanisms of anemia in CKD. J. Am. Soc. Nephrol. 23(10), 1631\u20131634 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"61003_CR8","doi-asserted-by":"publisher","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","volume":"9","author":"ME Stauffer","year":"2014","unstructured":"Stauffer, M. E. & Fan, T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One 9(1), e84943 (2014).","journal-title":"PLoS One"},{"issue":"3","key":"61003_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.ajkd.2017.09.026","volume":"71","author":"S Fishbane","year":"2018","unstructured":"Fishbane, S. & Spinowitz, B. Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018. Am. J. Kidney Dis. 71(3), 423\u2013435 (2018).","journal-title":"Am. J. Kidney Dis."},{"issue":"17","key":"61003_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa2035938","volume":"384","author":"GM Chertow","year":"2021","unstructured":"Chertow, G. M. et al. Vadadustat in patients with anemia and non-dialysis-dependent CKD. N. Engl. J. Med. 384(17), 1589\u20131600 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"61003_CR11","doi-asserted-by":"publisher","first-page":"i16","DOI":"10.1093\/ckj\/sfx043","volume":"10","author":"IC Macdougall","year":"2017","unstructured":"Macdougall, I. C. Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions. Clin. Kidney J. 10(Suppl 1), i16\u2013i24 (2017).","journal-title":"Clin. Kidney J."},{"issue":"5","key":"61003_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa1810742","volume":"380","author":"IC Macdougall","year":"2019","unstructured":"Macdougall, I. C. et al. Intravenous iron in patients undergoing maintenance hemodialysis. N. Engl. J. Med. 380(5), 447\u2013458 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"61003_CR13","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1681\/ASN.2013080838","volume":"25","author":"KL Kuo","year":"2014","unstructured":"Kuo, K. L. et al. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J. Am. Soc. Nephrol. 25(11), 2596\u20132606 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"61003_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ndt\/gfae095","volume":"39","author":"L Del Vecchio","year":"2024","unstructured":"Del Vecchio, L. et al. Iron biology. Nephrol. Dial. Transplant. 39(9), 1404\u20131415 (2024).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"61003_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ckj\/sfaa212","volume":"14","author":"L Del Vecchio","year":"2021","unstructured":"Del Vecchio, L. et al. Intravenous iron therapy and the cardiovascular system: risks and benefits. Clin. Kidney J. 14(4), 1067\u20131076 (2021).","journal-title":"Clin. Kidney J."},{"issue":"14","key":"61003_CR16","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak, M. J. et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 74(14), 1823\u20131838 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"61003_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","volume":"42","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh, K. et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am. J. Kidney Dis. 42(5), 864\u2013881 (2003).","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"61003_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22(4), 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"61003_CR19","first-page":"1","volume":"1","author":"P Carrilho","year":"2017","unstructured":"Carrilho, P. et al. Liver iron content by MRI at the start of hemodialysis. Adv. kidney Dis. Treat. 1(2), 1\u20138 (2017).","journal-title":"Adv. kidney Dis. Treat."},{"key":"61003_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fphar.2014.00094","volume":"5","author":"F Vinchi","year":"2014","unstructured":"Vinchi, F. et al. Atherogenesis and iron: from epidemiology to cellular level. Front. Pharmacol. 5, 94 (2014).","journal-title":"Front. Pharmacol."},{"issue":"8233","key":"61003_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(81)92463-6","volume":"1","author":"JL Sullivan","year":"1981","unstructured":"Sullivan, J. L. Iron and the sex difference in heart disease risk. Lancet 1(8233), 1293\u20131294 (1981).","journal-title":"Lancet"},{"issue":"10","key":"61003_CR22","doi-asserted-by":"publisher","first-page":"18792","DOI":"10.1002\/jcp.28518","volume":"234","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. J. Cell. Physiol. 234(10), 18792\u201318800 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"61003_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/01.ATV.15.8.1172","volume":"15","author":"JA Araujo","year":"1995","unstructured":"Araujo, J. A. et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler. Thromb. Vasc. Biol. 15(8), 1172\u20131180 (1995).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"61003_CR24","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/01.CIR.99.9.1222","volume":"99","author":"TS Lee","year":"1999","unstructured":"Lee, T. S. et al. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99(9), 1222\u20131229 (1999).","journal-title":"Circulation"},{"issue":"9","key":"61003_CR25","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.freeradbiomed.2005.01.008","volume":"38","author":"R Minqin","year":"2005","unstructured":"Minqin, R. et al. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic. Biol. Med. 38(9), 1206\u20131211 (2005).","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"61003_CR26","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.510290612","volume":"29","author":"S Brunet","year":"1999","unstructured":"Brunet, S. et al. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 29(6), 1809\u20131817 (1999).","journal-title":"Hepatology"},{"issue":"5","key":"61003_CR27","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1172\/JCI111609","volume":"74","author":"JW Heinecke","year":"1984","unstructured":"Heinecke, J. W., Rosen, H. & Chait, A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74(5), 1890\u20131894 (1984).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"61003_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00001648-199403000-00015","volume":"5","author":"HI Morrison","year":"1994","unstructured":"Morrison, H. I. et al. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 5(2), 243\u2013246 (1994).","journal-title":"Epidemiology"},{"issue":"2","key":"61003_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0019-4832(12)60056-X","volume":"64","author":"MP Holay","year":"2012","unstructured":"Holay, M. P., Choudhary, A. A. & Suryawanshi, S. D. Serum ferritin-a novel risk factor in acute myocardial infarction. Indian Heart J. 64(2), 173\u2013177 (2012).","journal-title":"Indian Heart J."},{"issue":"3","key":"61003_CR30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","volume":"86","author":"JT Salonen","year":"1992","unstructured":"Salonen, J. T. et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern finnish men. Circulation 86(3), 803\u2013811 (1992).","journal-title":"Circulation"},{"issue":"15","key":"61003_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/01.CIR.97.15.1461","volume":"97","author":"TP Tuomainen","year":"1998","unstructured":"Tuomainen, T. P. et al. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97(15), 1461\u20131466 (1998).","journal-title":"Circulation"},{"key":"61003_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2261-9-34","volume":"9","author":"A Menke","year":"2009","unstructured":"Menke, A. et al. The association of biomarkers of iron status with peripheral arterial disease in US adults. BMC Cardiovasc. Disord. 9, 34 (2009).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"61003_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.amjcard.2011.09.032","volume":"109","author":"MM Rajapurkar","year":"2012","unstructured":"Rajapurkar, M. M. et al. Association of catalytic iron with cardiovascular disease. Am. J. Cardiol. 109(3), 438\u2013442 (2012).","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"61003_CR34","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1161\/01.CIR.89.6.2915","volume":"89","author":"DM Baer","year":"1994","unstructured":"Baer, D. M., Tekawa, I. S. & Hurley, L. B. Iron stores are not associated with acute myocardial infarction. Circulation 89(6), 2915\u20132918 (1994).","journal-title":"Circulation"},{"issue":"12","key":"61003_CR35","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0735-1097(02)02611-6","volume":"40","author":"H Gaenzer","year":"2002","unstructured":"Gaenzer, H. et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J. Am. Coll. Cardiol. 40(12), 2189\u20132194 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"61003_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1096\/fj.05-4700fje","volume":"20","author":"AE Kartikasari","year":"2006","unstructured":"Kartikasari, A. E. et al. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J. 20(2), 353\u2013355 (2006).","journal-title":"FASEB J."},{"issue":"1","key":"61003_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2006.08.012","volume":"194","author":"LJ van Tits","year":"2007","unstructured":"van Tits, L. J. et al. Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation. Atherosclerosis 194(1), 272\u2013278 (2007).","journal-title":"Atherosclerosis"},{"issue":"3","key":"61003_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1053\/jhep.2000.16265","volume":"32","author":"M Failla","year":"2000","unstructured":"Failla, M. et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 32(3), 569\u2013573 (2000).","journal-title":"Hepatology"},{"issue":"3","key":"61003_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0021-9150(00)00623-7","volume":"154","author":"ML Rasmussen","year":"2001","unstructured":"Rasmussen, M. L. et al. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 154(3), 739\u2013746 (2001).","journal-title":"Atherosclerosis"},{"issue":"12","key":"61003_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1161\/01.CIR.100.12.1268","volume":"100","author":"M Roest","year":"1999","unstructured":"Roest, M. et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100(12), 1268\u20131273 (1999).","journal-title":"Circulation"},{"issue":"12","key":"61003_CR41","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/01.CIR.100.12.1274","volume":"100","author":"TP Tuomainen","year":"1999","unstructured":"Tuomainen, T. P. et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100(12), 1274\u20131279 (1999).","journal-title":"Circulation"},{"issue":"2","key":"61003_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/CIRCULATIONAHA.104.496075","volume":"112","author":"C Ellervik","year":"2005","unstructured":"Ellervik, C. et al. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. Circulation 112(2), 185\u2013193 (2005).","journal-title":"Circulation"},{"issue":"2","key":"61003_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.atherosclerosis.2010.03.018","volume":"211","author":"MF Engberink","year":"2010","unstructured":"Engberink, M. F. et al. Hemochromatosis (HFE) genotype and atherosclerosis: increased susceptibility to iron-induced vascular damage in C282Y carriers?. Atherosclerosis 211(2), 520\u2013525 (2010).","journal-title":"Atherosclerosis"},{"issue":"3","key":"61003_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/jama.1994.03520030073031","volume":"272","author":"M Miller","year":"1994","unstructured":"Miller, M. & Hutchins, G. M. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA 272(3), 231\u2013233 (1994).","journal-title":"JAMA"},{"key":"61003_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-026-05796-8","author":"A Ruban Agarvas","year":"2026","unstructured":"Ruban Agarvas, A. et al. Ferritin and transferrin predict common carotid intima-media thickness in females: a machine-learning informed individual participant data meta-analysis. BMC Cardiovasc. Disord. https:\/\/doi.org\/10.1186\/s12872-026-05796-8 (2026).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"61003_CR46","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/C3MT00347G","volume":"6","author":"DB Kell","year":"2014","unstructured":"Kell, D. B. & Pretorius, E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics 6(4), 748\u2013773 (2014).","journal-title":"Metallomics"},{"issue":"5","key":"61003_CR47","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","volume":"21","author":"GRY De Meyer","year":"2024","unstructured":"De Meyer, G. R. Y. et al. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat. Rev. Cardiol. 21(5), 312\u2013325 (2024).","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"61003_CR48","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/ATVBAHA.122.318177","volume":"42","author":"P Puylaert","year":"2022","unstructured":"Puylaert, P. et al. Regulated necrosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 42(11), 1283\u20131306 (2022).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"61003_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","volume":"19","author":"AB Sanz","year":"2023","unstructured":"Sanz, A. B. et al. Regulated cell death pathways in kidney disease. Nat. Rev. Nephrol. 19(5), 281\u2013299 (2023).","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"61003_CR50","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s43587-024-00727-8","volume":"4","author":"C Qin","year":"2024","unstructured":"Qin, C. et al. The foam cell-derived exosomal miRNA novel-3 drives neuroinflammation and ferroptosis during ischemic stroke. Nat. Aging 4(12), 1845\u20131861 (2024).","journal-title":"Nat. Aging"},{"key":"61003_CR51","doi-asserted-by":"publisher","first-page":"103345","DOI":"10.1016\/j.redox.2024.103345","volume":"76","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. High expression levels of haem oxygenase-1 promote ferroptosis in macrophage-derived foam cells and exacerbate plaque instability. Redox Biol. 76, 103345 (2024).","journal-title":"Redox Biol."},{"issue":"15","key":"61003_CR52","doi-asserted-by":"publisher","first-page":"e23850","DOI":"10.1096\/fj.202401251R","volume":"38","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. A novel mechanism of ferroptosis inhibition-enhanced atherosclerotic plaque stability: YAP1 suppresses vascular smooth muscle cell ferroptosis through GLS1. FASEB J. 38(15), e23850 (2024).","journal-title":"FASEB J."},{"key":"61003_CR53","doi-asserted-by":"publisher","first-page":"117183","DOI":"10.1016\/j.biopha.2024.117183","volume":"178","author":"M Zhang","year":"2024","unstructured":"Zhang, M., Li, J. & Hu, W. The complex interplay between ferroptosis and atherosclerosis. Biomed. Pharmacother. 178, 117183 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"61003_CR54","doi-asserted-by":"publisher","first-page":"102987","DOI":"10.1016\/j.redox.2023.102987","volume":"69","author":"X Luo","year":"2024","unstructured":"Luo, X. et al. MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1\/NRF2 interaction. Redox Biol. 69, 102987 (2024).","journal-title":"Redox Biol."},{"key":"61003_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155724","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI155724 (2022).","journal-title":"J. Clin. Invest."},{"key":"61003_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-11-14","volume":"11","author":"M Junyent","year":"2010","unstructured":"Junyent, M. et al. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. the rationale and design of NEFRONA: a prospective, multicenter, observational cohort study. BMC Nephrol. 11, 14 (2010).","journal-title":"BMC Nephrol."},{"issue":"1","key":"61003_CR57","first-page":"119","volume":"30","author":"M Junyent","year":"2010","unstructured":"Junyent, M. et al. Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project. Nefrologia 30(1), 119\u2013126 (2010).","journal-title":"Nefrologia"},{"issue":"3","key":"61003_CR58","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ndt\/gfw039","volume":"32","author":"D Arroyo","year":"2017","unstructured":"Arroyo, D. et al. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study. Nephrol. Dial. Transplant. 32(3), 513\u2013520 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"61003_CR59","doi-asserted-by":"publisher","first-page":"100677","DOI":"10.1016\/j.xkme.2023.100677","volume":"5","author":"D Hain","year":"2023","unstructured":"Hain, D. et al. Iron-deficiency anemia in CKD: a narrative review for the kidney care team. Kidney Med. 5(8), 100677 (2023).","journal-title":"Kidney Med."},{"key":"61003_CR60","unstructured":"Organization WH. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. Licence: CC BY-NC-SA 3.0 IGO. Geneve2024"},{"issue":"7","key":"61003_CR61","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/ndt\/gfu038","volume":"29","author":"A Betriu","year":"2014","unstructured":"Betriu, A. et al. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study. Nephrol. Dial. Transplant. 29(7), 1415\u20131422 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"61003_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"JH Stein","year":"2008","unstructured":"Stein, J. H. et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of Echocardiography carotid intima-media thickness task force. endorsed by the society for vascular medicine. J. Am. Soc. Echocardiogr. 21(2), 93\u2013111 (2008).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"4","key":"61003_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000081812","volume":"18","author":"PJ Touboul","year":"2004","unstructured":"Touboul, P. J. et al. Mannheim intima-media thickness consensus. Cerebrovasc. Dis. 18(4), 346\u2013349 (2004).","journal-title":"Cerebrovasc. Dis."},{"issue":"suppl_2","key":"61003_CR64","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/ndt\/gfw459","volume":"32","author":"M van Diepen","year":"2017","unstructured":"van Diepen, M. et al. Prediction versus aetiology: common pitfalls and how to avoid them. Nephrol. Dial. Transplant. 32(suppl_2), ii1\u2013ii5 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"61003_CR65","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.ki.5002650","volume":"73","author":"KJ Jager","year":"2008","unstructured":"Jager, K. J. et al. Confounding: what it is and how to deal with it. Kidney Int. 73(3), 256\u2013260 (2008).","journal-title":"Kidney Int."},{"key":"61003_CR66","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing (2010)."},{"key":"61003_CR67","doi-asserted-by":"publisher","DOI":"10.21105\/joss.02017","author":"JC Brunson","year":"2020","unstructured":"Brunson, J. C. Ggalluvial: Layered grammar for alluvial plots. J. Open Source Softw. https:\/\/doi.org\/10.21105\/joss.02017 (2020).","journal-title":"J. Open Source Softw."},{"key":"61003_CR68","unstructured":"Brunson JC, Read QD. ggalluvial: Alluvial Plots in \u2018ggplot2\u2019. R package version 0.12.5. (2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61003-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61003-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61003-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:03:08Z","timestamp":1791244988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61003-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61003"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61003-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30953"}}